Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson Stress MRI for CAD in Atrial Fibrillation
NCT01710254Phase 2Completed
- Sponsor
- University of Utah
- Start
- Jan 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regadenoson in coronary artery disease (CAD), sponsored by University of Utah. Started Jan 2013; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01710254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710254.